NeuroTherapia, Inc.
- Biotech or pharma, therapeutic R&D
NeuroTherapia is a clinical stage company developing an orally available molecule to treat neuroinflammation. The Company has started a Phase 2a trial with AD subjects and is seeking follow on funding to support its development activities.